BioLine RX Ltd (BLRX) — Long-term Investment Intensity
BioLine RX Ltd (BLRX) has a Long-term Investment Intensity of 1.8% as of March 2018. Long-term investments of ILA1.00 Million represent 1.8% of total assets of ILA56.08 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BioLine RX Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
BioLine RX Ltd Long-term Investment Intensity (2017–2017)
This chart shows how BioLine RX Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of March 2018, the intensity stands at 1.8%, reflecting long-term investments of ILA1.00 Million against total assets of ILA56.08 Million ILA. Explore BLRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for BioLine RX Ltd (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for BioLine RX Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BioLine RX Ltd market capitalisation.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 1.6% | ILA1.00 Million | ILA60.97 Million | — |